AI Technology Group Inc. and AVM Biotechnology Inc. provided an update on their proposed merger, stating that funding dates are being extended to accommodate longer timelines for the merger and financial audit. The companies reaffirmed their commitment to completing the merger in 2026, aiming to support the growth of the combined organization.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AI Technology Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-000202), on January 14, 2026, and is solely responsible for the information contained therein.